Eisai Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3160400002
JPY
4,809.00
128 (2.73%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

783.4 k

Shareholding (Dec 2025)

FII

0.08%

Held by 2 FIIs

DII

99.92%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 21.93

 
2

Poor long term growth as Operating profit has grown by an annual rate -19.80% of over the last 5 years

3

With ROE of 5.71%, it has a very attractive valuation with a 1.39 Price to Book Value

4

Majority shareholders : FIIs

 
5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 1,316,796 Million (Large Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.08

stock-summary
Return on Equity

5.95%

stock-summary
Price to Book

1.54

Revenue and Profits:
Net Sales:
219,937 Million
(Quarterly Results - Dec 2025)
Net Profit:
17,844 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.36%
0%
4.36%
6 Months
-8.24%
0%
-8.24%
1 Year
11.58%
0%
11.58%
2 Years
-24.58%
0%
-24.58%
3 Years
-32.9%
0%
-32.9%
4 Years
-19.01%
0%
-19.01%
5 Years
-33.54%
0%
-33.54%

Eisai Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
2.56%
EBIT Growth (5y)
-19.80%
EBIT to Interest (avg)
21.93
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.74
Tax Ratio
21.30%
Dividend Payout Ratio
97.70%
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
6.79%
ROE (avg)
5.99%

Valuation key factors

Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
1.39
EV to EBIT
26.57
EV to EBITDA
13.46
EV to Capital Employed
1.43
EV to Sales
1.38
PEG Ratio
2.09
Dividend Yield
0.01%
ROCE (Latest)
5.37%
ROE (Latest)
5.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.08%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 11.44% vs -2.61% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 69.41% vs -31.32% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "219,937.00",
          "val2": "197,362.00",
          "chgp": "11.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28,002.00",
          "val2": "21,048.00",
          "chgp": "33.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,430.00",
          "val2": "1,442.00",
          "chgp": "-0.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17,844.00",
          "val2": "10,533.00",
          "chgp": "69.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "81.60%",
          "val2": "56.90%",
          "chgp": "2.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 6.42% vs -0.36% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 9.76% vs -22.96% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "789,400.00",
          "val2": "741,751.00",
          "chgp": "6.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "89,146.00",
          "val2": "86,150.00",
          "chgp": "3.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,755.00",
          "val2": "1,884.00",
          "chgp": "46.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8,120.00",
          "val2": "-3,049.00",
          "chgp": "-166.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "48,059.00",
          "val2": "43,784.00",
          "chgp": "9.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.40%",
          "val2": "63.00%",
          "chgp": "-0.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
219,937.00
197,362.00
11.44%
Operating Profit (PBDIT) excl Other Income
28,002.00
21,048.00
33.04%
Interest
1,430.00
1,442.00
-0.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17,844.00
10,533.00
69.41%
Operating Profit Margin (Excl OI)
81.60%
56.90%
2.47%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 11.44% vs -2.61% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 69.41% vs -31.32% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
789,400.00
741,751.00
6.42%
Operating Profit (PBDIT) excl Other Income
89,146.00
86,150.00
3.48%
Interest
2,755.00
1,884.00
46.23%
Exceptional Items
-8,120.00
-3,049.00
-166.32%
Consolidate Net Profit
48,059.00
43,784.00
9.76%
Operating Profit Margin (Excl OI)
62.40%
63.00%
-0.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 6.42% vs -0.36% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 9.76% vs -22.96% in Mar 2024

stock-summaryCompany CV
About Eisai Co., Ltd. stock-summary
stock-summary
Eisai Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available